Qrons Appoints Dr. Motti Ratmansky as Special Advisor for IND & Clinical Trial Preparations
08 mai 2019 09h00 HE
|
Qrons Inc.
New York, NY, May 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTC: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions to...